VieCure, a leading provider of intelligent software platforms for oncology care, has raised $43 million in funding to accelerate its mission to democratize access to precision medicine in community cancer care practices. The round was led by Mitch Rales, co-founder of Danaher, and Northpond Ventures, with significant participation from Durable Capital Partners, Socium Ventures - a venture firm backed by Cox Enterprises, and Sator Grove Holdings. Additionally, Mitch Rales and Howard 'Skip' Burris III, M.D., a past president of the American Society of Clinical Oncology (ASCO), have joined the company's Board of Directors.